Cargill, Inc. and Branhaven LLC, this week announced a non-exclusive agreement to license Neogen Corporation their patented BeefGen genomics tools.
BeefGen tools analyze bovine genetics to improve meat and milk production. Specific terms of the license agreement were not disclosed.
The BeefGen patented diagnostics are based on precise molecular tools that may be used to improve beef cattle carcass quality, production efficiency and nutritional value. BeefGen licensees, such as Neogen, will work with cattle feedstock breeders, cattle producers, feedlot operators and dairies to improve their herds through genetics-based, scientific data that will be used for breeding, tracking and management.
For beef cattle producers, these genetic tools help identify animals best suited to optimize weight gain, beef marbling, tenderness, red meat yield, rib eye quality and other important characteristics that maximize the value and yield from each animal harvested. This technology may also assist in identifying genetically superior animals for breeding purposes, which in turn would produce high quality calves.
"Cargill is excited to enter into this license agreement with Neogen to ensure that the work started over a decade ago by Cargill and its partners is utilized in the marketplace more broadly," George Kwasniak, vice president of business development for Cargill's animal protein group commented in a released statement.
Kwasniak said the technology and patents are complementary to Neogen's existing offerings.
"This agreement allows Neogen unencumbered access to extensive cattle genomic analytic and bioinformatic knowledge amassed by Cargill researchers and their partners," added Dr. Jason Lilly, Neogen's vice president of corporate development.
"This access to the intellectual property developed by one of the world's largest protein producers through years of research should significantly add to our efforts to continue providing the most useful and innovative animal genomic tools for worldwide cattle producers."